Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.

PubWeight™: 1.36‹?› | Rank: Top 10%

🔗 View Article (PMID 18160750)

Published in Indian J Med Res on November 01, 2007

Authors

V V Banu Rekha1, Rani Balasubramanian, Soumya Swaminathan, Rajeswari Ramachandran, Fathima Rahman, V Sundaram, K Thyagarajan, N Selvakumar, A R Adhilakshmi, Sheik Iliayas, P R Narayanan

Author Affiliations

1: Tuberculosis Research Centre (ICMR), Chennai, India.

Articles citing this

Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis (2009) 5.75

The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med (2011) 4.91

Geographic differences in time to culture conversion in liquid media: Tuberculosis Trials Consortium study 28. Culture conversion is delayed in Africa. PLoS One (2011) 1.38

Baseline predictors of sputum culture conversion in pulmonary tuberculosis: importance of cavities, smoking, time to detection and W-Beijing genotype. PLoS One (2012) 1.15

Sputum completion and conversion rates after intensive phase of tuberculosis treatment: an assessment of the Rwandan control program. BMC Res Notes (2012) 1.04

Adherence to tuberculosis treatment, sputum smear conversion and mortality: a retrospective cohort study in 48 Rwandan clinics. PLoS One (2013) 0.97

Drug-resistant tuberculosis in Mumbai, India: An agenda for operations research. Oper Res Health Care (2012) 0.90

Tuberculosis and diabetes mellitus - an underappreciated association. Arch Med Sci (2014) 0.88

Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus. Eur J Clin Pharmacol (2016) 0.86

Special populations and pharmacogenetic issues in tuberculosis drug development and clinical research. J Infect Dis (2015) 0.84

Delay in sputum smear conversion and outcomes of smear-positive tuberculosis patients: a retrospective cohort study in Bafoussam, Cameroon. BMC Infect Dis (2015) 0.83

Effect of type II diabetes mellitus on treatment outcomes of tuberculosis. Lung India (2014) 0.82

Five-year assessment of time of sputum smears conversion and outcome and risk factors of tuberculosis patients in central iran. Tuberc Res Treat (2015) 0.75

A Retrospective Analysis of Two-Month Sputum Smear Non-Conversion in New Sputum Smear Positive Tuberculosis Patients in the Free State Province, South Africa. J Public Health Africa (2014) 0.75

Predictors of delayed culture conversion among Ugandan patients. BMC Infect Dis (2017) 0.75

Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study. BMC Infect Dis (2016) 0.75

Clinical Correlates and Drug Resistance in HIV-Infected and -Uninfected Pulmonary Tuberculosis Patients in South India. World J AIDS (2016) 0.75

Prevalence and Impact of Diabetes Mellitus Among Patients with Active Pulmonary Tuberculosis in South Korea. Lung (2017) 0.75

Articles by these authors

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis (2012) 4.60

Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90

Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis (2002) 3.89

IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, south India. Tuber Lung Dis (1995) 3.76

Gender disparities in tuberculosis: report from a rural DOTS programme in south India. Int J Tuberc Lung Dis (2004) 2.64

Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial. Am J Respir Crit Care Med (2009) 2.64

Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Int J Tuberc Lung Dis (2009) 2.55

Rapid decline in prevalence of pulmonary tuberculosis after DOTS implementation in a rural area of South India. Int J Tuberc Lung Dis (2008) 2.43

Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. Int J Tuberc Lung Dis (2005) 2.41

Surveillance of drug resistance in tuberculosis in two districts of South India. Int J Tuberc Lung Dis (2002) 2.30

Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. J Clin Microbiol (2001) 2.28

Factors influencing the care-seeking behaviour of chest symptomatics: a community-based study involving rural and urban population in Tamil Nadu, South India. Trop Med Int Health (2003) 2.07

Reasons for non-compliance among patients treated under Revised National Tuberculosis Control Programme (RNTCP), Tiruvallur district, south India. Indian J Tuberc (2007) 2.04

Restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, India, by use of direct-repeat probe. J Clin Microbiol (1995) 1.95

Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis (2012) 1.89

Disruption of response regulator gene, devR, leads to attenuation in virulence of Mycobacterium tuberculosis. FEMS Microbiol Lett (2004) 1.86

A pilot study on willingness to participate in future preventive HIV vaccine trials. Indian J Med Res (2006) 1.85

Unseen and unheard: predictors of sexual risk behavior and HIV infection among men who have sex with men in Chennai, India. AIDS Educ Prev (2009) 1.83

Nutritional supplementation in HIV-infected individuals in South India: a prospective interventional study. Clin Infect Dis (2010) 1.78

Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis (2012) 1.72

Perceptions of tuberculosis patients about their physical, mental and social well-being: a field report from south India. Soc Sci Med (2005) 1.69

Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent. J Clin Microbiol (1997) 1.69

HIV in Indian MSM: reasons for a concentrated epidemic & strategies for prevention. Indian J Med Res (2011) 1.67

Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis. Clin Infect Dis (2003) 1.63

Tuberculosis prevalence surveys: rationale and cost. Int J Tuberc Lung Dis (2008) 1.63

Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis (2013) 1.62

Disruption of mptpB impairs the ability of Mycobacterium tuberculosis to survive in guinea pigs. Mol Microbiol (2003) 1.62

Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel. J Infect Dis (2012) 1.60

The origin of follicular dendritic cells in the mouse and the mechanism of trapping of immune complexes on them. Eur J Immunol (1984) 1.55

Can LED fluorescence microscopy replace Ziehl-Neelsen microscopy in tuberculosis detection? Int J Tuberc Lung Dis (2012) 1.53

Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51

Interferon gamma (IFNgamma) & interleukin-4 (IL-4) gene variants & cytokine levels in pulmonary tuberculosis. Indian J Med Res (2006) 1.50

Nutritional status of persons with HIV infection, persons with HIV infection and tuberculosis, and HIV-negative individuals from southern India. Clin Infect Dis (2008) 1.48

Active community surveillance of the impact of different tuberculosis control measures, Tiruvallur, South India, 1968-2001. Int J Epidemiol (2006) 1.48

Initial drug susceptibility profile of M. tuberculosis among patients under TB programme in South India. Int J Tuberc Lung Dis (2006) 1.48

Serum Nevirapine and Efavirenz concentrations and effect of concomitant rifampicin in HIV infected children on antiretroviral therapy. Indian Pediatr (2011) 1.47

Impact of BCG vaccination on tuberculin surveys to estimate the annual risk of tuberculosis infection in south India. Indian J Med Res (2006) 1.47

Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India. Indian J Med Res (2011) 1.46

Carbonic anhydrase II deficiency: diagnosis and carrier detection using differential enzyme inhibition and inactivation. Am J Hum Genet (1986) 1.44

Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease. Antimicrob Agents Chemother (2004) 1.44

Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N Engl J Med (1985) 1.39

A novel method of staining acid-fast bacilli in sputum containers. Indian J Med Res (2006) 1.39

Outcome of Prevention of Parent-to-Child Transmission of HIV in an Urban Population in Southern India. Indian Pediatr (2015) 1.38

Risk factors for non-adherence to directly observed treatment (DOT) in a rural tuberculosis unit, South India. Indian J Tuberc (2007) 1.38

Genomic interrogation of ancestral Mycobacterium tuberculosis from south India. Infect Genet Evol (2007) 1.37

Impact of HIV infection on the recurrence of tuberculosis in South India. J Infect Dis (2010) 1.37

Trend in the prevalence of TB infection and ARTI after implementation of a DOTS programme in south India. Int J Tuberc Lung Dis (2006) 1.36

Hypercoagulation and thrombophilia in liver disease. J Thromb Haemost (2007) 1.34

Status of re-registered patients for tuberculosis treatment under DOTS programme. Indian J Tuberc (2007) 1.34

CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South India. Antimicrob Agents Chemother (2009) 1.32

Diagnosis & treatment of tuberculosis in HIV co-infected patients. Indian J Med Res (2011) 1.30

Depressive symptoms and human immunodeficiency virus risk behavior among men who have sex with men in Chennai, India. Psychol Health Med (2009) 1.30

Association of conversion & cure with initial smear grading among new smear positive pulmonary tuberculosis patients treated with Category I regimen. Indian J Med Res (2006) 1.29

Socio-economic dimensions of tuberculosis control: review of studies over two decades from Tuberculosis Research Center. J Commun Dis (2006) 1.29

Management of multi drug resistance tuberculosis in the field: Tuberculosis Research Centre experience. Indian J Tuberc (2007) 1.28

Selected biological and behavioural risk factors associated with pulmonary tuberculosis. Int J Tuberc Lung Dis (2007) 1.27

Evaluation of post-treatment health-related quality of life (HRQoL) among tuberculosis patients. Int J Tuberc Lung Dis (2007) 1.26

The prevalence of tuberculosis in different economic strata: a community survey from South India. Int J Tuberc Lung Dis (2007) 1.25

Are community surveys to detect tuberculosis in high prevalence areas useful? Results of a comparative study from Tiruvallur District, South India. Int J Tuberc Lung Dis (2003) 1.25

Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial. Clin Infect Dis (2011) 1.24

First- and second-line drug resistance patterns among previously treated tuberculosis patients in India. Int J Tuberc Lung Dis (2010) 1.22

Evaluation of the phenol ammonium sulfate sedimentation smear microscopy method for diagnosis of pulmonary tuberculosis. J Clin Microbiol (2002) 1.21

Contribution of medical colleges to tuberculosis control in India under the Revised National Tuberculosis Control Programme (RNTCP): lessons learnt & challenges ahead. Indian J Med Res (2013) 1.21

Application of lot sampling of sputum AFB smears for the assessment of microscopy centres. Int J Tuberc Lung Dis (2005) 1.20

Impact of HIV/AIDS on mothers in southern India: a qualitative study. AIDS Behav (2008) 1.20

Quality assurance studies in eight State tuberculosis laboratories in India. Int J Tuberc Lung Dis (2003) 1.19

Roles of laboratories and laboratory systems in effective tuberculosis programmes. Bull World Health Organ (2007) 1.19

The influence of stigma on HIV risk behavior among men who have sex with men in Chennai, India. AIDS Care (2012) 1.18

Association of functional mutant homozygotes of the mannose binding protein gene with susceptibility to pulmonary tuberculosis in India. Tuber Lung Dis (1999) 1.18

Inefficiency of 0.3% carbol fuchsin in ziehl-neelsen staining for detecting acid-fast bacilli. J Clin Microbiol (2002) 1.16

A baseline survey of the prevalence of tuberculosis in a community in south India at the commencement of a DOTS programme. Int J Tuberc Lung Dis (2003) 1.16

Perceptions of a community sample about participation in future HIV vaccine trials in south India. AIDS Behav (2006) 1.16

Comparison of DNA sequencing, PCR-SSCP and PhaB assays with indirect sensitivity testing for detection of rifampicin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis (2003) 1.15

Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda. PLoS Med (2008) 1.15

Impact of advocacy on the tuberculosis management practices of private practitioners in Chennai City, India. Int J Tuberc Lung Dis (2009) 1.15

Excess mortality and risk factors for mortality among a cohort of TB patients from rural south India. Int J Tuberc Lung Dis (2008) 1.15

Regulatory role of vitamin D receptor gene variants of Bsm I, Apa I, Taq I, and Fok I polymorphisms on macrophage phagocytosis and lymphoproliferative response to mycobacterium tuberculosis antigen in pulmonary tuberculosis. J Clin Immunol (2004) 1.15

Evaluation of PCR using TRC(4) and IS6110 primers in detection of tuberculous meningitis. J Clin Microbiol (2001) 1.13

Suppressive activity of splenic adherent cells from Plasmodium chabaudi-infected mice. J Immunol (1980) 1.13

Mortality of tuberculosis patients in Chennai, India. Bull World Health Organ (2006) 1.12

Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction. PLoS One (2013) 1.12